STAGE IV CERVICAL CANCER AJCC V8
Clinical trials for STAGE IV CERVICAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV CERVICAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV CERVICAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially bladder cancer. The main goals are to find the safest dose and understand side effects. About 7…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
Personalized cell therapy trial for advanced cancers withdrawn before enrollment
Disease control TerminatedThis early-stage trial aimed to test the safety and effectiveness of STIL101, a personalized cell therapy made from a patient's own tumor-fighting T cells, for several advanced cancers including pancreatic, colorectal, kidney, cervical, and melanoma. The treatment involved collec…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New online tool aims to ease cancer worry in women with advanced disease
Symptom relief OngoingThis study tests an online program called Day by Day to help women with stage III or IV gynecologic cancer manage their fear of the cancer growing or coming back. About 23 women will use the program and answer questionnaires to see if it is easy to use and helps reduce anxiety. T…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 26, 2026 04:17 UTC
-
Blood test may tame Chemo's nerve pain
Knowledge-focused TerminatedThis study looks at whether regularly measuring the amount of paclitaxel (a chemotherapy drug) in the blood can help doctors give the right dose to kill cancer while limiting nerve damage. About 22 adults with various solid tumors (like lung, breast, or ovarian cancer) will have …
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 04:15 UTC